Transcription of the etc gene in Bacillus subtilis is activated only after exponentially growing cells enter stationary phase. The promoter of the ctc gene is utilized in vitro by two minor forms of RNA polymerase, Ec37 and Eu32, but not by the most abundant form of RNA polymerase, Er-55. We have used the ctc promoter to direct transcription of the xylE gene on plasmid pLC4 and observed that xylE was expressed only in stationary-phase B. subtilis. We also have constructed a series of homologous plasmids that differ only by specific base substitutions in the ctc promoter. We observed that the base substitutions that affected utilization of the ctc promoter in vivo (xylE expression) were the same as those that we had previously shown to affect utilization of the promoter in vitro by Ea37 and Eu32. We conclude that it is likely that the ctc promoter is utilized in vivo by Ecr37 or Eu32.
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In response to nutrient depletion, the gram-positive bacterium Bacillus subtilis can undergo a complex cellular differentiation which leads to the production of a dormant endospore. Nutrient depletion also can trigger other morphological and physiological responses, including the induction of motility and the development of competence for DNA uptake. When certain nutrients are depleted, the exponential growth phase ends, and transcription of several genes is activated from promoters that are utilized in vitro by minor forms of RNA polymerase (see reference 7 for a review).
RNA polymerase from eubacteria is composed of several protein subunits; of these, the u subunit enables RNA polymerase to bind to specific promoters (14) . B. subtilis possesses several forms of RNA polymerase that differ by their cr subunit and, thereby, their specificity for promoter recognition. Ea37, one of the minor forms of RNA polymerase found in exponentially growing B. subtilis, contains a 37,000-dalton a subunit ((J37), and another form, Ea32, contains a 32,000-dalton a subunit (a32) (4, 6) . In vitro, these two forms of RNA polymerase utilize the promoters for several genes that are known to be transcribed in vivo only after the exponential growth phase (early stationary phase) (4, 6, 15) . These promoters are not utilized in vitro by the most abundant form of RNA polymerase in growing cells (Ea55), but there is no direct evidence that these promoters are utilized in vivo by Ea37 and Ec32 (e.g., transcription of these genes has not been examined in mutants having altered c32 or a37). We previously reported the effects of a series of base substitutions on utilization in vitro of the ctc promoter by Ea37 and E-2 (5, 12; K. M. Tatti, T. S. Kenney, R. E. Hay, and C. P. Moran, Jr., Gene, in press). In this report, we examine the effects of the base substitutions on utilization of the promoter in vivo.
MATERIALS AND METHODS
Bacterial strains, plasmids, and enzymes. The B. subtilis strain used is the sporulation-proficient strain JH642 (trpC2 phe-J) provided by J. Hoch. Plasmid pTG402, which was used to construct pLC4, was a gift from Transgene, Inc. (16) . Plasmids were amplified in Escherichia coli JM83, obtained from Bethesda Research Laboratories, and plasmid DNA * Corresponding author. was prepared by alkaline lysis followed by centrifugation in cesium chloride-ethidium bromide density gradients (1) . Restriction endonucleases were obtained from Boehringer Mannheim Chemicals or Bethesda Research Laboratories and were used as described in the recommendations of the suppliers.
Transformations. Plasmid DNA was introduced into JM83 by the CaCl2 procedure of Mandel and Higa (9) , and transformants were selected on LB (0.5% yeast extract, 1% tryptone, 0.5% NaCI) containing 50 p.g of ampicillin per ml. Plasmids were introduced into B. subtilis JH642 by transformation of competent cells (2) , and the transformants were selected on LB supplemented with 5 jig of chloramphenicol per ml.
Construction of plasmid pLC4. Plasmid pLC4 was derived from pTG402 (16) (see Fig. 2 phosphate buffer (pH 7.2) and centrifuged, and the cell pellets were frozen overnight at -80°C. Pellets were suspended in 2 ml of APEL buffer (100 mM potassium phosphate [pH 7.5], 20 mM EDTA, 10% acetone, 1 mg of lysozyme per ml) and incubated for 20 min at 37°C. Cells were then placed on ice for 15 min after addition of 20 ,ul of 10% Triton X-100. Extracts were centrifuged for 5 min at 10,000 rpm and 4°C to pellet cellular debris. Catechol 2,3-dioxygenase (CatO2ase) specific activities were determined spectrophotometrically (16) at 30°C in a total volume of 3 ml which contained 0.25 ml of cell extract, 2.75 ml of 100 mM potassium phosphate (pH 7.5), and 0.2 mM catechol. One milliunit corresponds to the formation of 1 nmol of 2-hydroxymuconic semialdehyde per min at 30°C. Protein concentrations were measured by the Bio-Rad assay with bovine serum albumin as the standard. All assays were performed with cells that had been recently transformed with pLC4-derived plasmids isolated from E. coli. Cells from each hourly sample were plated on LB and LB-chloramphenicol to demonstrate that the plasmid had not been lost during growth. Production of CatO2ase by colonies on plates was monitored by spraying with an aqueous solution of 0.5 M catechol as described previously (16) .
RNA preparation. RNA was purified by centrifugation through CsCl by a modification of the procedure of McDonald et al. (8) . B. subtilis JH642 containing pCR31 was grown in LB-chloramphenicol medium. One hour after the exponential growth phase, the cells were harvested by centrifugation and suspended in 3 ml of lysis buffer (100 mM Tris [pH 6.8], 2 mM EDTA, 3 mg of lysozyme per ml). After incubation for 10 min at 37°C, 0.15 ml of 20% (wt/vol) sodium dodecyl sulfate was added, and the sample was boiled for 5 min. The sample was placed on ice, 30 RI of 2 M KCl was added, and then the sample was allowed to stand on ice for an additional 30 min. The sample was centrifuged for 10 min at 8,000 rpm in a Sorvall SS34 rotor. The volume of the supernatant solution was made up to 3 ml by the addition of 0.4 ml of 0.5 M EDTA (pH 8.0) and H20. This solution was centrifuged through CsCl as described previously (8 (Fig. 2) (Table 1 ). This arrangement directed transcription from the promoter through xylE, which encodes the ribosome-binding site, start codon, and structural gene for CatO2ase (Fig. 2) . The other principal features of the pLC4 derivatives include their ability to replicate in both E. coli and B. subtilis and the expression of ampicillin resistance in E. coli and chloramphenicol resistance in both E. coli and B. subtilis. These pLC4 derivatives were isolated from E. coli and then transformed into B. subtilis, from which transformants were selected by their resistance to chloramphenicol. The synthesis of CatO2ase by a transformant was monitored at 1-h intervals after inoculation into LB-glucose-chloramphenicol medium. The specific activity of CatO2ase in B. subtilis containing plasmid pCR31, the pLC4 derivative with the wild-type ctc promoter, increased rapidly as the cells entered stationary phase (Fig. 3) . B. subtilis containing pLC4 did not make detectable amounts of CatO2ase (Table 1) .
B. subtilis containing pCR15, the pLC4 derivative with a ctc promoter having a single-base substitution (transition) at position -15 of the ctc promoter, produced a reduced amount of CatO2ase (Fig. 3) ments. The 145-bp DNA fragment also was excised and recloned between the EcoRI and HindIII restriction endonuclease cleavage sites of M13mp9, where we showed by nucleotide sequence analysis that the promoter contained only the original single-base substitution (data not shown). We concluded that the low level of synthesis Qf CatO2ase was a result of the single-base substitution at position -15 of the ctc promoter.
Si nuclease mapping of the ctc transcript. If transcription of xylE in pCR31 was initiated by EF&'7I or E&2 at the ctc promoter, then this transcription should have been initiated 95 bases upstream from the HindIII cleavage site. Si nuclease mapping experiments were used to map the 5' termini of the RNA transcripts that were encoded by this region of the plasmid. RNA isolated from B. subtilis cells which contained pCR31 was annealed to pCR31 DNA that had been labeled with 32P at the 5' terminus of the HindlIl site. This RNA protected 95 bases of this DNA from S1 nuclease digestion (Fig. 4) . RNA encoded by the ctc gene found in the chromosome of this strain could not have protected this DNA since the HindIII site and the preceding 15 nucleotides of pCR31 are not homologous with the chromosomal ctc gene. We conclude that the transcript originated from the plasmid at the start point of the ctc promoter. Because we did not observe protected DNA fragments longer than 95 bases, we conclude that transcription did not originate at a unique site upstream from the promoter; therefore, the role of 'the ctc promoter in the expression of xylE is probably not antitermination of transcripts originating upstream. We also have used pCR31 DNA labeled with 32P at the 5' terminus of the AvaI site that lies within xylE as a probe in Si nuclease mapping experiments. In this case, the transcript protected approximately 1.1 kilobases of DNA, which is the distance between the AvaI site and the ctc promoter (data not shown). (Fig. 4) . Finally, several base substitutions in the ctc promoter prevented expression of xylE (see below); therefore, xylE expression was dependent on transcription initiated at the ctc promoter.
We examined the effects of base substitutions in the ctc promoter on expression of xylE by constructing a series of plasmids that were homologous to pCR31 except for different base substitutions in the ctc promoter. We showed previously that the promoters in plasmids pCR36, pCR16, pCR15, pCR14, pCR12, pCR1415, and pCR46 were not utilized efficiently in vitro by Ecr37 and Eu32, whereas the promoters in the other eight plasmids in Table 1 
